Vivoryon Therapeutics N.V. (0R3M.L)

EUR 1.9

(-2.46%)

Total Assets Summary of Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.'s latest annual total assets in 2023 was 30.82 Million EUR , down -1.75% from previous year.
Vivoryon Therapeutics N.V.'s latest quarterly total assets in 2024 Q2 was 16.99 Million EUR , down 0.0% from previous quarter.
Vivoryon Therapeutics N.V. reported annual total assets of 31.37 Million EUR in 2022, up 27.97% from previous year.
Vivoryon Therapeutics N.V. reported annual total assets of 24.52 Million EUR in 2021, down -17.58% from previous year.
Vivoryon Therapeutics N.V. reported quarterly total assets of 30.82 Million EUR for 2023 Q4, down 0.0% from previous quarter.
Vivoryon Therapeutics N.V. reported quarterly total assets of 45.35 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of Vivoryon Therapeutics N.V. (2023 - 2010)

Historical Annual Total Assets of Vivoryon Therapeutics N.V. (2023 - 2010)

Year	Total Assets	Total Assets Growth
2023	30.82 Million EUR	-1.75%
2022	31.37 Million EUR	27.97%
2021	24.52 Million EUR	-17.58%
2020	29.75 Million EUR	-35.13%
2019	45.86 Million EUR	1132829.84%
2018	4048.00 EUR	-62.39%
2017	10.76 Thousand EUR	-51.88%
2016	22.36 Thousand EUR	2.29%
2015	21.86 Thousand EUR	1.8%
2014	21.48 Thousand EUR	-99.66%
2013	6.37 Million EUR	-36.29%
2012	10 Million EUR	-47.6%
2011	19.09 Million EUR	19.59%
2010	15.96 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	16.99 Million EUR	0.0%
2023 Q4	30.82 Million EUR	0.0%
2023 Q2	45.35 Million EUR	0.0%
2023 FY	30.82 Million EUR	-1.75%
2022 Q2	31.74 Million EUR	0.0%
2022 FY	31.37 Million EUR	27.97%
2022 Q4	31.37 Million EUR	0.0%
2021 FY	24.52 Million EUR	-17.58%
2021 Q2	23.04 Million EUR	0.0%
2021 Q4	24.52 Million EUR	0.0%
2020 Q4	29.75 Million EUR	0.0%
2020 FY	29.75 Million EUR	-35.13%
2020 Q2	37.9 Million EUR	0.0%
2019 FY	45.86 Million EUR	1132829.84%
2019 Q4	45.86 Million EUR	0.0%
2019 Q2	9.26 Million EUR	0.0%
2018 FY	4048.00 EUR	-62.39%
2018 Q2	7169.00 EUR	0.0%
2018 Q4	4048.00 EUR	0.0%
2017 Q2	14.97 Thousand EUR	0.0%
2017 FY	10.76 Thousand EUR	-51.88%
2017 Q4	10.76 Thousand EUR	0.0%
2016 Q4	22.36 Thousand EUR	0.0%
2016 Q2	15.74 Thousand EUR	0.0%
2016 FY	22.36 Thousand EUR	2.29%
2015 Q2	15.38 Thousand EUR	0.0%
2015 Q4	21.86 Thousand EUR	0.0%
2015 FY	21.86 Thousand EUR	1.8%
2014 Q2	6604.00 EUR	0.0%
2014 Q4	21.48 Thousand EUR	0.0%
2014 FY	21.48 Thousand EUR	-99.66%
2013 Q4	6.37 Million EUR	0.0%
2013 FY	6.37 Million EUR	-36.29%
2012 FY	10 Million EUR	-47.6%
2011 FY	19.09 Million EUR	19.59%
2010 FY	15.96 Million EUR	0.0%

Peer Total Assets Comparison of Vivoryon Therapeutics N.V.

Name	Total Assets	Total Assets Difference
Boiron SA	590.2 Million EUR	94.777%
Laboratorios Farmaceuticos Rovi, S.A.	799.88 Million EUR	96.146%
Vetoquinol SA	692.23 Million EUR	95.546%
Valneva SE	469.39 Million EUR	93.432%
AB Science S.A.	25.49 Million EUR	-20.903%
Nanobiotix S.A.	93.89 Million EUR	67.167%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	39.913%
BioSenic S.A.	9.55 Million EUR	-222.513%
ABIVAX Société Anonyme	327.06 Million EUR	90.574%
Formycon AG	890.36 Million EUR	96.537%